Former Genentech employees charged with trade secrets theft

Alex Tse, US attorney for the Northern District of California, has charged three former Genentech employees with trade secrets theft.

Already registered?

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk

More on this story

Americas

Chinese national jailed for stealing medical devices tech

30 January 2019 A US district court has sentenced a Chinese national to 27 months in federal prison for the theft of trade secrets from two American medical device manufacturers.

Big Pharma

Genentech enters agreement to develop autoimmune therapies

21 May 2019 US-based biopharmaceutical company Parvus Therapeutics has entered into a collaboration and licensing agreement with Genentech, a subsidiary of Roche.

Americas

Taiwanese biotech abandons drug R&D under Genentech MoU

10 September 2019 Taiwanese company JHL Biotech will stop developing biosimilar versions of Genentech’s drugs as part of a memorandum of understanding signed by the parties to end trade secrets litigation.

More on this story

Americas

Chinese national jailed for stealing medical devices tech

30 January 2019 A US district court has sentenced a Chinese national to 27 months in federal prison for the theft of trade secrets from two American medical device manufacturers.

Big Pharma

Genentech enters agreement to develop autoimmune therapies

21 May 2019 US-based biopharmaceutical company Parvus Therapeutics has entered into a collaboration and licensing agreement with Genentech, a subsidiary of Roche.

Americas

Taiwanese biotech abandons drug R&D under Genentech MoU

More on this story

Americas

Chinese national jailed for stealing medical devices tech

30 January 2019 A US district court has sentenced a Chinese national to 27 months in federal prison for the theft of trade secrets from two American medical device manufacturers.

Big Pharma

Genentech enters agreement to develop autoimmune therapies

21 May 2019 US-based biopharmaceutical company Parvus Therapeutics has entered into a collaboration and licensing agreement with Genentech, a subsidiary of Roche.

Americas

Taiwanese biotech abandons drug R&D under Genentech MoU